Ocular myasthenia revisited: insights from pseudo-internuclear ophthalmoplegia.
Ocular myasthenia can mimic central disorders of eye movements. We compared horizontal saccades in two patients with myasthenia gravis who presented as pseudo-internuclear ophthalmoplegia (pseudo-INO), two patients with true INO due to multiple sclerosis (MS), and five healthy subjects. In myasthenics, peak velocity of horizontal saccades was similar to, or greater than, controls; in MS patients, adducting saccades were slower than controls. Differences between the peak velocity of abducting and adducting eyes for each saccade were similar to controls for myasthenic pseudo-INO, but greater than controls for true INO. Using the technique of phase-plane analysis, in which eye velocity is plotted against eye position, we found that initial components of abducting and adducting saccades in the myasthenics were as conjugate as controls, even though later components of myasthenic saccades were highly and variably disjunctive. Conversely, phase planes of saccades in true INO showed disjunctive early components of abducting and adducting saccades. Two hypotheses have been offered to account for preservation of fast saccades despite reduced range of eye movements in ocular myasthenia. The first is intrasaccadic neuromuscular fatigue, which is variable over time. Our finding that initial components of saccades were consistently conjugate in the myasthenics gives support to a second hypothesis: selective sparing of pale global fibers, which are important for generating highspeed eye movements, and which are unique amongst extraocular fibers in possessing well developed synaptic folding.
Khanna
Sangeeta
S
Daroff-Dell'Osso Laboratory, Department of Neurology, Veterans Affairs Medical Center and University Hospitals Case Western Reserve University, Cleveland, Ohio 44106, USA.
Liao
Ke
K
Kaminski
Henry J
HJ
Tomsak
Robert L
RL
Joshi
Anand
A
Leigh
R John
RJ
D000328:Adult; D004585:Electrooculography / Q000379:methods; D005133:Eye Movements / Q000502:physiology*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009103:Multiple Sclerosis / Q000150:complications; D009157:Myasthenia Gravis / Q000150:complications* / Q000175:diagnosis; D015835:Ocular Motility Disorders / Q000209:etiology*; D009801:Oculomotor Muscles / Q000503:physiopathology
Neurology. 1983 Sep;33(9):1157-63
6684251
Curr Treat Options Neurol. 2005 Jan;7(1):79-88
15610710
Semin Neurol. 2004 Mar;24(1):21-30
15229789
Philos Trans R Soc Lond B Biol Sci. 2000 Dec 29;355(1404):1685-754
11205338
Arch Ophthalmol. 1987 Dec;105(12):1703-11
3318773
Proc Biol Sci. 1994 Dec 22;258(1353):321-6
21710792
Arch Ophthalmol. 1976 Jul;94(7):1083-5
938289
Invest Ophthalmol Vis Sci. 1999 Jul;40(8):1681-6
10393036
Neurology. 1998 Oct;51(4):1093-9
9781535
Neurologist. 2006 Sep;12(5):231-9
16990734
Arch Ophthalmol. 1983 Feb;101(2):211-3
6824463
Muscle Nerve. 2006 Apr;33(4):445-61
16228970
Semin Neurol. 2000;20(1):7-20
10874773
Arch Ophthalmol. 1966 Mar;75(3):363-6
5903821
J Neurol Sci. 1997 May 1;148(1):53-65
9125391
J Neurol Neurosurg Psychiatry. 2002 Jul;73(1):51-5
12082045
Arch Ophthalmol. 1976 Sep;94(9):1465-72
962656
Arch Ophthalmol. 1973 Oct;90(4):319-22
4746649
Prog Brain Res. 2006;151:43-80
16221585